BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36220785)

  • 1. Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency.
    Belanger AJ; Gefteas E; Przybylska M; Geller S; Anarat-Cappillino G; Kloss A; Yew NS
    J Inherit Metab Dis; 2023 Jan; 46(1):55-65. PubMed ID: 36220785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of ureagenesis in the spf
    Allegri G; Deplazes S; Rimann N; Causton B; Scherer T; Leff JW; Diez-Fernandez C; Klimovskaia A; Fingerhut R; Krijt J; Kožich V; Nuoffer JM; Grisch-Chan HM; Thöny B; Häberle J
    J Inherit Metab Dis; 2019 Nov; 42(6):1064-1076. PubMed ID: 30714172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency.
    McGuire PJ; Tarasenko TN; Wang T; Levy E; Zerfas PM; Moran T; Lee HS; Bequette BJ; Diaz GA
    Dis Model Mech; 2014 Feb; 7(2):205-13. PubMed ID: 24271778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine restores ureagenesis capacity and mitigates hyperammonemia in Otc(spf-ash) mice.
    Marini JC; Lee B; Garlick PJ
    J Nutr; 2006 Jul; 136(7):1834-8. PubMed ID: 16772445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model.
    Mao X; Chen H; Lin AZ; Kim S; Burczynski ME; Na E; Halasz G; Sleeman MW; Murphy AJ; Okamoto H; Cheng X
    J Inherit Metab Dis; 2022 May; 45(3):470-480. PubMed ID: 34988999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced ornithine transcarbamylase activity does not impair ureagenesis in Otc(spf-ash) mice.
    Marini JC; Lee B; Garlick PJ
    J Nutr; 2006 Apr; 136(4):1017-20. PubMed ID: 16549467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T
    Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting neutral amino acid transport for the treatment of phenylketonuria.
    Belanger AM; Przybylska M; Gefteas E; Furgerson M; Geller S; Kloss A; Cheng SH; Zhu Y; Yew NS
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.
    Marini JC; Lanpher BC; Scaglia F; O'Brien WE; Sun Q; Garlick PJ; Jahoor F; Lee B
    Am J Clin Nutr; 2011 Jun; 93(6):1248-54. PubMed ID: 21490144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.
    Tarasenko TN; Rosas OR; Singh LN; Kristaponis K; Vernon H; McGuire PJ
    PLoS One; 2015; 10(2):e0116594. PubMed ID: 25647322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
    Batshaw ML; Yudkoff M; McLaughlin BA; Gorry E; Anegawa NJ; Smith IA; Hyman SL; Robinson MB
    Gene Ther; 1995 Dec; 2(10):743-9. PubMed ID: 8750014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
    Scaglia F; Carter S; O'Brien WE; Lee B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dogfish shark (Squalus acanthias) increases both hepatic and extrahepatic ornithine urea cycle enzyme activities for nitrogen conservation after feeding.
    Kajimura M; Walsh PJ; Mommsen TP; Wood CM
    Physiol Biochem Zool; 2006; 79(3):602-13. PubMed ID: 16691526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia.
    Tuchman M; Yudkoff M
    Mol Genet Metab; 1999 Jan; 66(1):10-5. PubMed ID: 9973542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: analysis of OTC-deficient spf-ash mice with OTC transgene.
    Saheki T; Mori K; Kobayashi K; Horiuchi M; Shige T; Obara T; Suzuki S; Mori M; Yamamura K
    Biochim Biophys Acta; 1995 Jan; 1270(1):87-93. PubMed ID: 7827141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of ornithine transcarbamylase deficiency in spf and spf-ash mutant mice.
    Ohtake A; Takayanagi M; Yamamoto S; Kakinuma H; Nakajima H; Tatibana M; Mori M
    J Inherit Metab Dis; 1986; 9(3):289-91. PubMed ID: 3099076
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.